Protea Fund - Sectoral Biotech Opportunities Fund Class IF H Fonds
10,03
CHF
+0,09
CHF
+0,91
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 7,71% |
| Gilead Sciences Inc | US3755581036 | 6,89% |
| Amgen Inc | US0311621009 | 6,72% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,93% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,74% |
| AstraZeneca PLC ADR | US0463531089 | 4,55% |
| argenx SE ADR | US04016X1019 | 4,48% |
| Insmed Inc | US4576693075 | 3,94% |
| BeOne Medicines Ltd ADR | US07725L1026 | 3,15% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 2,39% |
| Sonstige | 50,50% |